Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MRVI · against 348 other Healthcare companies of similar size
Ranked #209 of 349 · scores higher than 40% of peers · safety percentile 43
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)36 peers with a safety percentile of 40–49, including MRVI · Click a bar to see the companies
A mix: stronger current ratio, but weaker debt / equity than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | MRVI | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 337 reported | 0.61× | 0.23× | 27% | 33% | |
| BetaLower is better · 334 reported | 0.54 | 0.56 | 51% | 33% | |
| Current ratioHigher is better · 335 reported | 4.05× | 2.82× | 66% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 2.6B USD | 100 | 43 | |
| 3 | 3.6B USD | 99 | ||
| 4 | 1.8B USD | 99 | 42 | |
| 5 | 2.2B USD | 99 | 48 | |
| 205 | 13.8B CNY (≈$1.9B) | 45 | 51 | |
| 206 | 26.6B CNY (≈$3.7B) | 44 | 57 | |
| 207 | 2.2B USD | 43 | 23 | |
| 208 | 16.3B CNY (≈$2.3B) | 43 | 49 | |
| 209 | 2.8B USD | 43 | 22 | |
| 210 | 2.2B USD | 43 | 61 | |
| 211 | 1.5B EUR (≈$1.7B) | 42 | 60 | |
| 212 | 21.1B HKD (≈$2.7B) | 42 | 67 | |
| 213 | 23.0B CNY (≈$3.2B) | 42 | 64 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score